Q1 2024 · 13F-HR
Artal Group S.A.holdings as filed
Filed 2024-05-13 · accession 0001053906-24-000005
$3.92B
Reported value
110
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 148929102 | CAVA | CAVA GROUP INC | $1.86B | 47.4% | 26,507,990 | Common | SOLE |
| 528872302 | LXRX | Lexicon Pharmaceuticals Inc | $282.1M | 7.20% | 117,553,284 | Common | SOLE |
| 80706P103 | SRRK | Scholar Rock Hldg Corp | $200.0M | 5.10% | 11,259,438 | Common | SOLE |
| 501575104 | KYMR | Kymera Therapeutics Inc | $121.7M | 3.10% | 3,027,135 | Common | SOLE |
| 04280A100 | ARWR | Arrowhead Pharmaceuticals Inc | $86.8M | 2.22% | 3,036,668 | Common | SOLE |
| 61775R105 | MORFUSD | Morphic Hldg Inc | $77.9M | 1.99% | 2,213,188 | Common | SOLE |
| 03753U106 | APLSUSD | Apellis Pharmaceuticals Inc | $77.3M | 1.97% | 1,315,282 | Common | SOLE |
| 85205L107 | SWTXUSD | SpringWorks Therapeutics Inc | $69.7M | 1.78% | 1,415,348 | Common | SOLE |
| 22663K107 | CRNX | Crinetics Pharmaceuticals Inc | $65.1M | 1.66% | 1,390,477 | Common | SOLE |
| 07725L102 | ONC | Beigene Ltd | $63.3M | 1.62% | 404,782 | Common | SOLE |
| 82686Q101 | SLN | Silence Therapeutics PLC | $60.0M | 1.53% | 2,779,619 | Common | SOLE |
| 26818M108 | DYN | Dyne Therapeutics Inc | $43.1M | 1.10% | 1,517,960 | Common | SOLE |
| 76155X100 | RVMD | Revolution Medicines Inc | $42.5M | 1.08% | 1,318,649 | Common | SOLE |
| 50127T109 | KURA | Kura Oncology Inc | $41.0M | 1.04% | 1,919,884 | Common | SOLE |
| 640979100 | NMRA | Neumora Therapeutics Inc | $40.2M | 1.03% | 2,924,052 | Common | SOLE |
| 500946108 | KRRO | Korro Bio Inc | $37.7M | 0.96% | 419,226 | Common | SOLE |
| 23282W605 | CYTK | Cytokinetics Inc | $35.5M | 0.91% | 506,584 | Common | SOLE |
| 83422E204 | SLDB | Solid Biosciences Inc | $33.3M | 0.85% | 2,500,000 | Common | SOLE |
| 449585108 | 1K0 | IGM Biosciences Inc | $29.7M | 0.76% | 3,080,422 | Common | SOLE |
| 558868105 | MDGL | Madrigal Pharmaceuticals Inc | $29.5M | 0.75% | 110,507 | Common | SOLE |
| 38000Q102 | GLYCEUR | GlycoMimetics Inc | $25.8M | 0.66% | 8,589,064 | Common | SOLE |
| Y95308105 | WVE | WAVE Life Sciences Ltd | $25.0M | 0.64% | 4,051,400 | Common | SOLE |
| G72800108 | PRTA | Prothena Corp PLC | $24.8M | 0.63% | 1,001,360 | Common | SOLE |
| 78464A870 | XBI | Spdr Ser Tr | $23.7M | 0.61% | 250,000 | CALL | SOLE |
| 92337R101 | VERA | Vera Therapeutics Inc | $21.8M | 0.56% | 506,019 | Common | SOLE |
| 92686J106 | VKTX | Viking Therapeutics Inc | $20.8M | 0.53% | 253,863 | Common | SOLE |
| N5749R100 | 2GH | Merus N V | $20.5M | 0.52% | 455,081 | Common | SOLE |
| N62509109 | NAMS | NewAmsterdam Pharma Company | $18.9M | 0.48% | 800,000 | Common | SOLE |
| 87583X109 | TNGX | Tango Therapeutics Inc | $17.4M | 0.44% | 2,194,841 | Common | SOLE |
| 04280A100 | ARWR | Arrowhead Pharmaceuticals Inc | $17.2M | 0.44% | 600,000 | CALL | SOLE |
| 00445A100 | — | Acelyrin Inc | $16.2M | 0.41% | 2,405,143 | Common | SOLE |
| 02083G100 | NVLSEUR | Alpine Immune Sciences Inc | $16.1M | 0.41% | 405,784 | Common | SOLE |
| 152309100 | CNTA | Centessa Pharmaceuticals PLC | $16.0M | 0.41% | 1,412,500 | Common | SOLE |
| 38341P102 | GOSS | Gossamer Bio Inc | $15.7M | 0.40% | 13,308,968 | Common | SOLE |
| 28036F105 | EWTX | Edgewise Therapeutics Inc | $14.8M | 0.38% | 811,718 | Common | SOLE |
| 87184Q206 | SYRS | Syros Pharmaceuticals Inc | $13.4M | 0.34% | 2,505,013 | Common | SOLE |
| 81141R100 | SE | Sea Ltd | $12.8M | 0.33% | 237,500 | Common | SOLE |
| 52886X107 | LXEO | Lexeo Therapeutics Inc | $12.6M | 0.32% | 801,716 | Common | SOLE |
| 04635X102 | CATBUSD | Astria Therapeutics Inc | $12.4M | 0.32% | 884,214 | Common | SOLE |
| 03152W109 | AM6 | Amicus Therapeutics Inc | $11.9M | 0.30% | 1,011,776 | Common | SOLE |
| 37148K100 | GBIOGBX | Generation Bio Co | $11.5M | 0.29% | 2,830,591 | Common | SOLE |
| 98420N105 | XENE | Xenon Pharmaceuticals Inc | $10.9M | 0.28% | 253,387 | Common | SOLE |
| 15117B202 | CLDX | Celldex Therapeutics Inc New | $10.6M | 0.27% | 253,000 | Common | SOLE |
| 877619106 | TSHA | Taysha Gene Therapies Inc | $10.6M | 0.27% | 3,687,548 | Common | SOLE |
| 24823R105 | DNLI | Denali Therapeutics Inc | $10.3M | 0.26% | 502,899 | Common | SOLE |
| 03770N101 | APGE | Apogee Therapeutics Inc | $10.1M | 0.26% | 152,500 | Common | SOLE |
| 29479A108 | ERAS | Erasca Inc | $9.7M | 0.25% | 4,721,194 | Common | SOLE |
| 00847G705 | AGENEUR | Agenus Inc | $9.1M | 0.23% | 15,631,235 | Common | SOLE |
| 81578P106 | SEER | Seer Inc | $9.0M | 0.23% | 4,750,000 | Common | SOLE |
| 90400D108 | RARE | Ultragenyx Pharmaceutical Inc | $8.3M | 0.21% | 177,932 | Common | SOLE |
| 28623U101 | — | Elevation Oncology Inc | $7.8M | 0.20% | 1,513,015 | Common | SOLE |
| 690469101 | OVID | Ovid Therapeutics Inc | $7.6M | 0.19% | 2,500,000 | Common | SOLE |
| 89157D105 | TRML | Tourmaline Bio Inc | $7.2M | 0.18% | 314,496 | Common | SOLE |
| 03828A101 | APLT | Applied Therapeutics Inc | $6.9M | 0.18% | 1,009,500 | Common | SOLE |
| 722304102 | PDD | PDD Holdings Inc | $6.6M | 0.17% | 56,500 | Common | SOLE |
| 86366E106 | GPCR | Structure Therapeutics Inc | $6.5M | 0.17% | 151,780 | Common | SOLE |
| 92673K108 | VIGL | Vigil Neuroscience Inc | $6.2M | 0.16% | 1,811,191 | Common | SOLE |
| 05464T104 | AXSM | Axsome Therapeutics Inc | $6.1M | 0.16% | 76,837 | Common | SOLE |
| 816212104 | SELBUSD | Cartesian Therapeutics Inc | $5.9M | 0.15% | 9,136,635 | Common | SOLE |
| 09203E105 | BDTX | Black Diamond Therapeutics Inc | $5.3M | 0.14% | 1,046,517 | Common | SOLE |
| 75901B107 | RGNX | Regenxbio Inc | $5.3M | 0.13% | 250,000 | Common | SOLE |
| 019818103 | — | Allovir Inc | $5.0M | 0.13% | 6,597,167 | Common | SOLE |
| 501976104 | KYTX | Kyverna Therapeutics Inc | $5.0M | 0.13% | 200,000 | Common | SOLE |
| 344174107 | FHTX | Foghorn Therapeutics Inc. | $4.8M | 0.12% | 720,720 | Common | SOLE |
| 68217N105 | — | Omega Therapeutics Inc | $4.8M | 0.12% | 1,323,530 | Common | SOLE |
| 874039100 | TSM | Taiwan Semiconductor Mfg Ltd | $4.4M | 0.11% | 32,000 | Common | SOLE |
| 374163103 | GERN | Geron Corp | $4.2M | 0.11% | 1,281,194 | Common | SOLE |
| 86150R107 | STOK | Stoke Therapeutics Inc | $4.0M | 0.10% | 300,000 | Common | SOLE |
| 43906K100 | HOOKGBP | HOOKIPA Pharma Inc | $4.0M | 0.10% | 5,666,410 | Common | SOLE |
| 786700104 | SGMT | Sagimet Biosciences Inc | $3.9M | 0.10% | 724,771 | Common | SOLE |
| 70450Y103 | PYPL | PayPal Hldgs Inc | $3.9M | 0.10% | 58,000 | CALL | SOLE |
| 482497104 | BEKE | Ke Holdings Inc | $3.8M | 0.10% | 275,000 | Common | SOLE |
| 760273102 | RPTX | Repare Therapeutics Inc | $3.3M | 0.08% | 700,000 | Common | SOLE |
| 59102M104 | MGX | Metagenomi Inc | $3.2M | 0.08% | 300,000 | Common | SOLE |
| 713317105 | PEPG | PepGen Inc | $2.9M | 0.08% | 200,000 | Common | SOLE |
| 005329107 | ADAG | Adagene Inc | $2.9M | 0.07% | 1,020,000 | Common | SOLE |
| 39868T105 | 2JQ | Gritstone Bio Inc | $2.6M | 0.07% | 1,030,952 | Common | SOLE |
| 31189P102 | FATE | Fate Therapeutics Inc | $2.6M | 0.07% | 360,311 | Common | SOLE |
| 929033108 | — | Vor Biopharma Inc | $2.4M | 0.06% | 1,000,000 | Common | SOLE |
| 023135106 | AMZN | Amazon Com Inc | $2.2M | 0.06% | 12,000 | Common | SOLE |
| 47103J105 | JANX | Janux Therapeutics Inc | $1.9M | 0.05% | 50,000 | Common | SOLE |
| 67066G104 | NVDA | NVIDIA Corporation | $1.7M | 0.04% | 1,900 | Common | SOLE |
| 037833100 | AAPL | Apple Inc | $1.7M | 0.04% | 10,000 | Common | SOLE |
| 268150109 | DT | Dynatrace Inc | $1.7M | 0.04% | 36,000 | Common | SOLE |
| 00724F101 | ADBE | Adobe Inc | $1.6M | 0.04% | 3,100 | Common | SOLE |
| 647581206 | EDU | New Oriental Ed & Technology | $1.3M | 0.03% | 15,000 | Common | SOLE |
| 23804L103 | DDOG | Datadog Inc | $1.2M | 0.03% | 9,600 | Common | SOLE |
| 50107A104 | KRON1USD | Kronos Bio Inc | $1.1M | 0.03% | 842,954 | Common | SOLE |
| 02079K305 | GOOGL | Alphabet Inc | $1.1M | 0.03% | 7,000 | Common | SOLE |
| 594918104 | MSFT | Microsoft Corp | $1.1M | 0.03% | 2,500 | Common | SOLE |
| 833445109 | SNOW | Snowflake Inc | $1.1M | 0.03% | 6,500 | Common | SOLE |
| 45827U109 | INTA | Intapp Inc | $1.0M | 0.03% | 29,500 | Common | SOLE |
| 46333X108 | IRWD | Ironwood Pharmaceuticals Inc | $962,734 | 0.02% | 110,532 | Common | SOLE |
| 00449L102 | 698 | Achilles Therapeutics PLC | $944,219 | 0.02% | 755,375 | Common | SOLE |
| 697435105 | PANW | Palo Alto Networks Inc | $852,390 | 0.02% | 3,000 | Common | SOLE |
| 007903107 | AMD | Advanced Micro Devices Inc | $812,205 | 0.02% | 4,500 | Common | SOLE |
| 74275K108 | PCOR | Procore Technologies Inc | $780,615 | 0.02% | 9,500 | Common | SOLE |
| 705573103 | PEGA | Pegasystems Inc | $743,360 | 0.02% | 11,500 | Common | SOLE |
| 60937P106 | MDB | MongoDB Inc | $717,280 | 0.02% | 2,000 | Common | SOLE |
| 92826C839 | V | Visa Inc | $697,700 | 0.02% | 2,500 | Common | SOLE |
| 70450Y103 | PYPL | PayPal Hldgs Inc | $669,900 | 0.02% | 10,000 | Common | SOLE |
| 20717M103 | 8QR | Confluent Inc | $579,880 | 0.01% | 19,000 | Common | SOLE |
| 142038108 | CRBU | Caribou Biosciences Inc | $541,484 | 0.01% | 105,347 | Common | SOLE |
| 23255M204 | CYCN | Cyclerion Therapeutics Inc | $444,656 | 0.01% | 138,955 | Common | SOLE |
| 185123106 | CWAN | Clearwater Analytics Hldgs I | $442,250 | 0.01% | 25,000 | Common | SOLE |
| G29018101 | DLO | Dlocal Ltd | $441,000 | 0.01% | 30,000 | Common | SOLE |
| 433539202 | HIPO | Hippo Hldgs Inc | $438,480 | 0.01% | 24,000 | Common | SOLE |
| 88160R101 | TSLA | Tesla Inc | $351,580 | 0.01% | 2,000 | Common | SOLE |
| 38341P102 | GOSS | Gossamer Bio Inc | $244,260 | 0.01% | 207,000 | CALL | SOLE |
| 603693102 | — | Mink Therapeutics Inc | $1,740 | 0.00% | 1,916 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.